[Recent advances in the application of TAT, TM, t-PAIC and PIC in thromboembolism].
Zhonghua Yu Fang Yi Xue Za Zhi
; 57(10): 1693-1703, 2023 Oct 06.
Article
in Zh
| MEDLINE
| ID: mdl-37859391
ABSTRACT
Thromboembolism is a crucial part of the global disease burden. It has high incidence, high mortality and disability rates, and the mechanism of occurrence and development is extremely complex. It is difficult to detect the disease in the early stage so that we have trouble with clinical prevention and treatment in general. At present, four items of blood coagulation and D-dimer have been widely used in the evaluation and auxiliary diagnosis of thromboembolism, the monitoring of effect for antithrombotic drugs and other fields. The thrombus biomarkers including thrombin-antithrombin complex (TAT), thrombomodulin (TM), tissue plasminogen activator-inhibitor complex (t-PAIC) and α2-plasmin inhibitor-plasmin complex (PIC) fill the gap of laboratory diagnosis before clinical symptoms appear in some degree. This article aims to explain the current application status of TAT, TM, t-PAIC and PIC in thromboembolism and explore their potential application value, so as to provide a reference for selecting appropriate early monitoring indicators for high-risk population of thromboembolism.
Full text:
1
Database:
MEDLINE
Main subject:
Thromboembolism
/
Tissue Plasminogen Activator
Limits:
Humans
Language:
Zh
Year:
2023
Type:
Article